GANX
Pharmaceuticals, Biotechnology & Life Sciences
CROWD: RED
Active holders jumped 13 to 11 recently (-15% in one quarter). Ten years of our own data says fast institutional pile-ins mark late money, not early money. Careful chasing this.
Active holders
11
of 42 total, index funds excluded
This quarter
+2
4 out
Conviction
n/a
Streak
0q
consecutive rising quarters
The crowd, 2016 to now
active holders per quarter
2021Mar 2026
Holdings as of Mar 31, 2026, filed by May 16, 2026. Counts for the newest quarter keep settling for a few weeks as amendments land.
The tide
funds in (up) vs out (down)
Top holders
by reported value · $16M held
Fund
Value
Note
MARSHALL WACE, LLP
$3M
Potomac Capital Management,…
$2M
JONES FINANCIAL COMPANIES L…
$1M
Cambridge Investment Resear…
$1M
DME Capital Management, LP
$1M
GEODE CAPITAL MANAGEMENT, L…
$869K
SUSQUEHANNA INTERNATIONAL G…
$837K
VANGUARD CAPITAL MANAGEMENT…
$776K
GSA CAPITAL PARTNERS LLP
$606K
VANGUARD FIDUCIARY TRUST CO
$446K
Tourists vs true believers
every holder a dot · right = bigger bet in their own book, up = patient money
Hover any dot for the fund and its bet size. Patience is measured from each filer's actual quarter-to-quarter turnover across our whole database.